Safety of MT-401-OTS in Patients With Relapsed AML or MDS
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to MDS
Related studies linked through entity extraction aliases.
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE1
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study
- Status
- RECRUITING
- Phase
- N/A
Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML
- Status
- COMPLETED
- Phase
- N/A
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
- Status
- RECRUITING
- Phase
- N/A
Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Efficacy and Mechanism of Yisui Granule in Treatment of Low and Medium Risk Myelodysplastic Syndrome Through Demethylation
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Global Registry and Natural History Study for Mitochondrial Disorders
- Status
- RECRUITING
- Phase
- N/A
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
- Status
- TERMINATED
- Phase
- PHASE2
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3